![](https://investorshub.advfn.com/uicon/305797.png?cb=1557061686)
Sunday, July 05, 2020 3:22:36 PM
Just taking the article that was linked earlier I don't really see anything I disagree with. Hydroxycloroquine has been demonized by our media and stated many times that it is very dangerous, while the big pharma companies that run advertising on those networks have interests in discrediting a cheap solution like hydroxycloroquine and promoting their much more expensive solutions like remdesivir or the vaccines they are waiting on. The Lancet and NEJM had to pull articles stating the dangerous effects of hydroxycloroquine because the papers were supposedly based on totally fake data made up by a team from Surgisphere that consisted of a science fiction writer and a adult entertainment model. Our western media used these studies non-stop to provide more evidence that their viewers should definitely not use hydroxycloroquine and tied it in to their constant anti-Trump coverage.
I read an article a few days ago that the Henry Ford Health System in Michigan unleashed a study that they were seeing around 50% less daaths of COVID-19 patients treated with hydroxycloroquine than those who were not.
So, at the end of the day, I wouldn't totally trust RT but I take their articles individually by their own merit and compare it against a lot of the propaganda we get fed in our own western media. I don't see a problem with the hydroxycloroquine article that was linked earlier with the revelation of recent data that seems to coroborate it. After all, big pharma would not profit nearly to the extent if a cheap and fairly safe treatment is able to be an effective cure and also it would give positive press to President Trump.
Recent NWBO News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM